menu
    • menu

    Company profile for HitGen

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DNA Encoded Library (DEL) is an innovative drug discovery technology rapidly gaining wide spread interest in the pharmaceutical industry in recent years. It combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to create vast number of novel molecules for hit identification and lead generation. HitGen has been building a large collection of novel, diverse and drug...
    DNA Encoded Library (DEL) is an innovative drug discovery technology rapidly gaining wide spread interest in the pharmaceutical industry in recent years. It combines the power of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics to create vast number of novel molecules for hit identification and lead generation. HitGen has been building a large collection of novel, diverse and drug-like DELs as its primary drug discovery platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HitGenChina Flag
    Country
    Country
    China
    Address
    Address
    Building 6, No.8, Huigu 1st East Road Tianfu International Bio-Town Shuangliu ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hitgen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hitgen-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ESG | Hitgen Releases 2025 Sustainability Report
    ESG | Hitgen Releases 2025 Sustainability Report

    29 Apr 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/esg--hitgen-releases-2025-sustainability-report-302756819.html

    PR NEWSWIRE BIO
    29 Apr 2026
    Share Share
    Hitgen Submits Commitment Letter To Science Based Targets
    Hitgen Submits Commitment Letter To Science Based Targets

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hitgen-submits-commitment-letter-to-science-based-targets-initiative-sbti-302641794.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    HitGen Secures Funding for Underserved Therapeutics
    HitGen Secures Funding for Underserved Therapeutics

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hitgen-receives-new-funding-to-discover-novel-therapeutics-for-underserved-diseases-302619703.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    BioAge & HitGen Begin Phase 1 Study of BGE-102, NLRP3 Inhibitor
    BioAge & HitGen Begin Phase 1 Study of BGE-102, NLRP3 Inhibitor

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hitgen-partner-bioage-labs-initiates-phase-1-clinical-study-of-bge-102-a-novel-brain-penetrant-nlrp3-inhibitor-302554934.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    HitGen Launches OpenDEL™ 5.0 for Enhanced Research Technology
    HitGen Launches OpenDEL™ 5.0 for Enhanced Research Technology

    27 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/advancing-del-technology-for-the-research-lab-hitgen-introduces-opendel-5-0--302539772.html

    PR NEWSWIRE
    27 Aug 2025
    Share Share
    Mission BioCapital Announces 2024 Platinum Ticket Investments
    Mission BioCapital Announces 2024 Platinum Ticket Investments

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mission-biocapital-announces-2024-platinum-ticket-investments-and-opening-of-4-million-2025-platinum-program-contest-302421769.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search